pamidronate has been researched along with hydroxyproline in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (33.80) | 18.7374 |
1990's | 44 (61.97) | 18.2507 |
2000's | 2 (2.82) | 29.6817 |
2010's | 1 (1.41) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Evans, AJ; Hosking, DJ; Marshall, DH; Perkins, AC; Stone, MD; Wastie, ML | 1 |
Fogelman, I; Gibson, T; Ryan, PJ; Sherry, M | 1 |
Burckhardt, P; Portmann, L; Thiébaud, D | 1 |
Fogelman, I; Gibson, T; Ryan, PJ | 1 |
Berman, A; Mautalen, C; Santini, AE; Spindler, A; Ubios, J | 1 |
Clarke, NW; George, NJ; McClure, J | 1 |
Boyce, BF; Boyle, IT; Gallacher, SJ; Jenkins, A; Patel, U; Ralston, SH | 1 |
Barto, R; Hackeng, WH; Leeuwenkamp, OR; Lips, P; Netelenbos, JC; van der Vijgh, WJ; van der Wiel, H; van Ginkel, FC | 1 |
Clarke, NW; George, NJ; Holbrook, IB; McClure, J | 1 |
Grauer, A; Scharla, SH; Ziegler, R | 1 |
Barry-Walsh, C; Bhagat, CI; Fenton, AJ; Gutteridge, DH; Kent, GN; Price, RI; Retallack, RW; Thompson, RI; Watson, IG; Worth, GK | 1 |
Hawthorne, AB; Hosking, DJ; Kerr, D; Stone, MD; Webster, G | 1 |
Reid, IR; Schooler, BA; Stewart, AW | 1 |
Burckhardt, P; Jaeger, P; Thiebaud, D | 2 |
Kuntz, D; Miravet, L | 1 |
Bruce, F; Hacking, L; Pitkeathly, DA; Ralston, SH; Willocks, L | 1 |
Burckhardt, P; Jacquet, AF; Jaeger, P; Thiébaud, D | 1 |
Drake, S; Massie, JD; Palmieri, GM; Postlethwaite, AE | 1 |
Ames, R; Caughey, DE; Ibbertson, HK; Tan, PL; Yeoman, S | 1 |
Bijvoet, OL; Hoekman, K; Löwik, CW; Papapoulos, SE; Vermeij, P | 1 |
Bijvoet, OL; Blanksma, HJ; Dahlinghaus-Nienhuys, PJ; Harinck, HI | 1 |
Bijvoet, OL; Body, JJ; Borkowski, A; Cleeren, A | 1 |
Gray, DH; Ibbertson, HK; Katz, JM; Reid, IR | 1 |
Bijvoet, OL; Blanksma, HJ; Harinck, HI; Moolenaar, AJ; Papapoulos, SE; Vermeij, P | 1 |
Burckhardt, P; Gobelet, C; Jacquet, AF; Jaeger, P; Thiébaud, D | 1 |
Bijvoet, OL; Frolich, M; Harinck, HI; Mudde, AH; Papapoulos, SE; vd Berg, H | 1 |
Coleman, RE; Rubens, RD | 1 |
Bijvoet, OL; Hoekman, K; Papapoulos, SE; Peters, AC | 1 |
Anderson, DC; Dewis, P; Prasad, BK; Willets, S | 1 |
Ghiringhelli, G; Gonzalez, D; Mautalen, CA | 1 |
Mautalen, CA | 1 |
Dodd, G; Fraser, TR; Holdaway, IM; Ibbertson, HK; King, A; Rutland, M; Wattie, DJ | 1 |
Bijvoet, OL; de Vries, E; Frijlink, WB; Jie, K; Meijer, CJ; Mulder, H; Reitsma, PH; te Velde, J; van der Linden, H; van der Wey, JP; van Paassen, HC | 1 |
Bijvoet, OL; Reitsma, PH; van der Wee-Pals, LJ; Verlinden-Ooms, H | 1 |
Bijvoet, OL; Delwaide, P; Franchimont, P; Heynen, G | 1 |
Bijvoet, OL; Potokar, M; Reitsma, PH; van der Wee-Pals, LJ; van Wijk-van Lennep, MM | 1 |
Bijvoet, OL; Frijlink, WB; Reitsma, PH; van Breukelen, FJ; Vismans, FJ | 1 |
Browning, S; Fram, RJ; George, S; Glover, D; Keller, A; Lipton, A; Macerata, RS; Miller, AA; Seaman, JJ; Zelenakas, K | 1 |
Landman, JO; Papapoulos, SE | 1 |
Coupland, CA; Hosking, DJ; Patel, S; Stone, MD | 1 |
Breedveld, FC; Dijkmans, BA; Eggelmeijer, F; Papapoulos, SE; van Paassen, HC | 1 |
Chakravarty, K; Merry, P; Scott, DG | 1 |
Delmas, PD; Liens, D; Meunier, PJ | 1 |
Bombassei, GJ; Raisz, LG; Yocono, M | 1 |
Mautalen, C; Pérez Lloret, A; Roldán, EJ; Vega, E | 1 |
Cornish, J; Evans, MC; Gamble, GD; Reid, IR; Stapleton, JP; Wattie, DJ | 1 |
Davie, MW; Rowlands, PR; Sharp, CA; Worsfold, M | 1 |
Anderson, DC; Brown, JK; Buckler, HM; Cantrill, JA; Denton, J; Freemont, AJ; Hargreaves, S; Hollis, S; Richardson, PC | 1 |
Fritz, P; Kuntz, D; Lioté, F | 1 |
Grauer, A; Klar, B; Scharla, SH; Zieglar, R | 1 |
Bhagat, CI; Gutteridge, DH; Kent, GN; Nicholson, GC; Prince, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Ward, LC | 1 |
Clemens, JD; Dresner-Pollak, R; Greenspan, SL; Moses, AC; Rosen, HN; Rosenblatt, M; Zeind, AJ | 1 |
Colwell, A; Eastell, R; Hamdy, NA; Papapoulos, SE; Russell, RG | 1 |
Harada, K; Inaba, M; Ishimura, E; Koyama, H; Miki, T; Morii, H; Nakatsuka, K; Nishizawa, Y | 1 |
Gunasekera, RD; Wimalawansa, SJ | 1 |
Coupland, C; Hosking, DJ; Patel, S; Stone, MD | 1 |
Chen, T; Greenspan, SL; Gundberg, C; Holick, M; Kung, VT; Moses, AC; Rosen, HN; Seyedin, SM | 1 |
Bhagat, CI; Gutteridge, DH; Johnston, CA; Kent, GN; Nicholson, GC; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG | 1 |
Meunier, PJ; Vignot, E | 1 |
Body, JJ; Dumon, JC; Ford, J; Piccart, M | 1 |
Bergmann, P; Body, JJ; Dumon, JC; Ham, H; Hotimski, A; Moris, M; Peretz, A; Praet, JP; Rozenberg, S | 1 |
Bhagat, CI; Gutteridge, DH; Kent, GN; Nicholson, GC; Price, RI; Prince, RL; Retallack, RW; Stewart, GO; Stuckey, BG; Thompson, RI; Ward, LC | 1 |
Coleman, RE; Eastell, R; Guo, CY; Purohit, OP; Vinholes, J | 1 |
Body, JJ; Delmas, PD; Dumon, JC; Gineyts, E | 1 |
Hyldstrup, L; Kollerup, G; Storm, T; Sørensen, HA | 1 |
Green, JR; Jee, WS; Li, QN; Ma, YF; Müller, K; Pataki, A | 1 |
Blayney, D; Heffernan, M; Hortobagyi, GN; Knight, RD; Lipton, A; Mellars, K; Porter, L; Reitsma, DJ; Seaman, JJ; Simeone, JF; Sinoff, C; Theriault, RL; Wheeler, H | 1 |
Cremers, S; den, HJ; Hamdy, N; Papapoulos, S; Sparidans, R; Vermeij, P | 1 |
Alvarez, V; Casco, C; Mautalen, C; Rubinstein, M; Tau, C | 1 |
Afsie, S; Al-Nammari, SS; Timothy, T | 1 |
1 review(s) available for pamidronate and hydroxyproline
Article | Year |
---|---|
A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
Topics: Alendronate; Alkaline Phosphatase; Arthropathy, Neurogenic; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Humans; Hydroxyproline; Imidazoles; Immobilization; Insulin-Like Growth Factor I; Pamidronate; Randomized Controlled Trials as Topic; RANK Ligand; Skin Temperature; Zoledronic Acid | 2013 |
23 trial(s) available for pamidronate and hydroxyproline
Article | Year |
---|---|
Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer.
Topics: Alkaline Phosphatase; Bone Neoplasms; Bone Resorption; Calcium; Creatinine; Diphosphonates; Humans; Hydroxyproline; Male; Osteocalcin; Pamidronate; Prostatic Neoplasms | 1992 |
Clinical experience with pamidronate in the treatment of Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Time Factors | 1991 |
Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Bone and Bones; Diphosphonates; Humans; Hydroxyproline; Male; Middle Aged; Neoplasm Metastasis; Osteoclasts; Pamidronate; Prostatic Neoplasms; Radiography | 1991 |
Prevention of glucocorticoid-induced osteoporosis.
Topics: Adult; Alkaline Phosphatase; Calcitriol; Clinical Trials as Topic; Diphosphonates; Female; Glucocorticoids; Humans; Hydroxyproline; Male; Middle Aged; Osteocalcin; Osteoporosis; Pamidronate; Prospective Studies | 1990 |
Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Calcium; Clinical Trials as Topic; Creatinine; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Male; Middle Aged; Pamidronate; Radiography; Random Allocation | 1989 |
Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Topics: Administration, Oral; Alkaline Phosphatase; Biopsy; Bone and Bones; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Osteitis Deformans; Pamidronate; Remission Induction; Time Factors | 1987 |
Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
Topics: Aged; Alkaline Phosphatase; Clinical Trials as Topic; Creatinine; Diphosphonates; Etidronic Acid; Humans; Hydroxyproline; Middle Aged; Osteitis Deformans; Pamidronate | 1985 |
Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Analgesics, Opioid; Bone Neoplasms; Breast Neoplasms; Calcium; Creatinine; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Infusions, Intravenous; Middle Aged; Pain; Palliative Care; Pamidronate; Remission Induction | 1994 |
Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Remodeling; Diphosphonates; Follow-Up Studies; Half-Life; Humans; Hydroxyproline; Infusions, Intravenous; Linear Models; Osteitis Deformans; Pamidronate | 1995 |
Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study.
Topics: Adult; Arthritis, Rheumatoid; Bone and Bones; Bone Resorption; Calcium; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Pamidronate; Radioimmunoassay | 1994 |
A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Child; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Infusions, Intravenous; Longitudinal Studies; Male; Middle Aged; Osteitis Deformans; Pain; Pamidronate; Prospective Studies | 1994 |
Effects of intravenous pamidronate therapy on Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium; Diphosphonates; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Pamidronate | 1994 |
Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
Topics: Aged; Alkaline Phosphatase; Body Temperature; Bone and Bones; Calcium; Diphosphonates; Ergocalciferols; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Tablets, Enteric-Coated | 1994 |
Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis.
Topics: Aged; Alkaline Phosphatase; Bone Density; Calcium; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Middle Aged; Osteoporosis, Postmenopausal; Pamidronate; Placebos; Spinal Fractures | 1994 |
Intravenous pamidronate: evolution of an effective treatment strategy.
Topics: Aged; Alkaline Phosphatase; Diphosphonates; Drug Administration Schedule; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans; Pamidronate; Radionuclide Imaging; Remission Induction; Severity of Illness Index | 1994 |
Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
Topics: Adolescent; Adult; Amino Acids; Analysis of Variance; Biomarkers; Bone Resorption; Calcium; Collagen; Collagen Type I; Creatinine; Diphosphonates; Humans; Hydroxyproline; Male; Pamidronate; Peptides; Thyrotropin; Triiodothyronine | 1994 |
Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
Topics: Alkaline Phosphatase; Calcitonin; Creatinine; Diphosphonates; Drug Administration Schedule; Drug Resistance; Etidronic Acid; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans; Pain; Pamidronate | 1993 |
Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans.
Topics: Adolescent; Adult; Amino Acids; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Male; Osteocalcin; Pamidronate; Parathyroid Hormone; Triiodothyronine | 1993 |
Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study.
Topics: Adult; Aged; Analysis of Variance; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcitriol; Calcium; Creatinine; Diphosphonates; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hydroxyproline; Infusions, Intravenous; Middle Aged; Osteolysis; Pamidronate; Parathyroid Hormone | 1995 |
Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Analysis of Variance; Bone and Bones; Diphosphonates; Female; Humans; Hydroxyproline; Infusions, Intravenous; Leukocyte Count; Longitudinal Studies; Male; Middle Aged; Neutrophils; Osteitis Deformans; Pain; Pain Measurement; Pamidronate; Recurrence | 1996 |
Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Biomarkers; Bone Neoplasms; Bone Resorption; Calcium; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Peptides | 1997 |
Assessment of different markers of bone resorption in postmenopausal osteoporotic women treated with pamidronate.
Topics: Aged; Amino Acids; Biomarkers; Bone Resorption; Chromatography, High Pressure Liquid; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Kinetics; Middle Aged; Osteoporosis, Postmenopausal; Pamidronate; Placebos | 1997 |
Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.
Topics: Alkaline Phosphatase; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calcium; Creatinine; Diphosphonates; Double-Blind Method; Female; Humans; Hydroxyproline; Osteolysis; Pain; Pamidronate; Survival Rate; Treatment Outcome | 1998 |
47 other study(ies) available for pamidronate and hydroxyproline
Article | Year |
---|---|
Bisphosphonate space measurement in Paget's disease of bone treated with APD.
Topics: Alkaline Phosphatase; Bone and Bones; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Paget Disease, Extramammary; Pamidronate; Regression Analysis; Technetium Tc 99m Medronate | 1992 |
Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Creatinine; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Palliative Care; Pamidronate; Time Factors | 1992 |
[Moderate Paget's disease treated with pamidronate (APD): experience in 43 patients with a single 60 mg infusion of varying duration of 1-to-24 hours].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Ambulatory Care; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Infusions, Parenteral; Male; Middle Aged; Osteitis Deformans; Pamidronate; Time Factors | 1992 |
Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
Topics: Alkaline Phosphatase; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans; Pain; Pamidronate; Radionuclide Imaging | 1992 |
Chronic idiopathic hyperphosphatasia. Report of a case treated with pamidronate and a review of the literature.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Chronic Disease; Diphosphonates; Female; Humans; Hydroxyproline; Pamidronate; Radiography | 1992 |
Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months.
Topics: 24,25-Dihydroxyvitamin D 3; Adult; Alkaline Phosphatase; Bone and Bones; Bone Development; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Humans; Hydroxyproline; Kinetics; Male; Osteocalcin; Pamidronate; Phosphates | 1991 |
[Therapy of Paget's disease with bisphosphonate pamidronate (AHPrBP, formerly APD)].
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Density; Diphosphonates; Female; Follow-Up Studies; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radiography | 1991 |
Intravenous aminobisphosphonate in Paget's disease: clinical, biochemical, histomorphometric and radiological responses.
Topics: Adult; Aged; Bone and Bones; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radiography | 1991 |
Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
Topics: Alkaline Phosphatase; Calcium; Diphosphonates; Drug Administration Schedule; Follow-Up Studies; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans; Pamidronate; Phosphates | 1990 |
Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone.
Topics: Bone and Bones; Breast Neoplasms; Calcium; Carcinoma, Squamous Cell; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Kidney; Male; Pamidronate | 1990 |
[Amino-hydroxy-propylidene biphosphonate in the treatment of Paget's disease resistant to calcitonin and/or etidronate].
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcitonin; Diphosphonates; Drug Administration Schedule; Drug Resistance; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate | 1989 |
[A single infusion of Pamidronate (APD) in Paget's disease of bone].
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Resorption; Diphosphonates; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate | 1989 |
Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Calcium-Binding Proteins; Diphosphonates; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Pamidronate; Radionuclide Imaging | 1989 |
Effects of aminobisphosphonate infusion on biochemical indices of bone metabolism in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Bone and Bones; Calcium; Calcium-Binding Proteins; Creatinine; Diphosphonates; Drug Evaluation; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Osteocalcin; Pamidronate | 1989 |
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate.
Topics: Administration, Oral; Aged; Animals; Bone and Bones; Bone Resorption; Clinical Protocols; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Mice; Middle Aged; Models, Biological; Organ Culture Techniques; Osteitis Deformans; Pamidronate; Prospective Studies | 1989 |
Treatment of malignancy-associated hypercalcemia with intravenous aminohydroxypropylidene diphosphonate.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Calcium; Cyclic AMP; Diphosphonates; Female; Head and Neck Neoplasms; Humans; Hydroxyproline; Hypercalcemia; Lung Neoplasms; Male; Middle Aged; Osteolysis; Pamidronate; Phosphorus | 1986 |
The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria.
Topics: Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Calcium; Diphosphonates; DNA; Drug Interactions; Hydrocortisone; Hydroxyproline; Mice; Organ Culture Techniques; Pamidronate; Parathyroid Hormone; Skull | 1986 |
Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Body Temperature; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Osteitis Deformans; Pamidronate; Retrospective Studies; Time Factors | 1987 |
A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium-Binding Proteins; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Pamidronate | 1988 |
Paget's disease of bone treated in five days with AHPrBP (APD) per Os.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate | 1987 |
Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium-Binding Proteins; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Pamidronate | 1987 |
3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Calcium; Diphosphonates; Female; Fluid Therapy; Humans; Hydroxyproline; Hypercalcemia; Middle Aged; Osteolysis; Pamidronate; Time Factors | 1987 |
Characteristics and bisphosphonate treatment of a patient with juvenile osteoporosis.
Topics: Adolescent; Calcitriol; Calcium; Diphosphonates; Humans; Hydroxyproline; Intestinal Absorption; Male; Osteoporosis; Pamidronate; Parathyroid Hormone; Radiography; Wrist | 1985 |
Efficacy of the bisphosphonate APD in the control of Paget's bone disease.
Topics: Adult; Aged; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Recurrence | 1985 |
Treatment of Paget's bone disease with the bisphosphonate APD.
Topics: Aged; Alkaline Phosphatase; Diphosphonates; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate | 1983 |
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
Topics: Aged; Alkaline Phosphatase; Calcitonin; Calcium; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Time Factors | 1984 |
APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
Topics: Animals; Arthritis, Rheumatoid; Calcitonin; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Hydroxyproline; Lymphocyte Activation; Osteitis Deformans; Pamidronate; Phagocytes; Rats; Zinc | 1980 |
Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Resorption; Calcification, Physiologic; Calcium; Diphosphonates; Histocytochemistry; Homeostasis; Hydroxyproline; Male; Pamidronate; Phosphates; Rats | 1980 |
Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
Topics: Alkaline Phosphatase; Calcium; Diphosphonates; Fever; Humans; Hydroxyproline; Osteitis Deformans; Pamidronate; Phosphorus | 1982 |
Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
Topics: Administration, Oral; Animals; Anthropometry; Bone and Bones; Bone Development; Bone Resorption; Calcium; Diphosphonates; Female; Hydroxyproline; Male; Pamidronate; Phosphates; Rats; Rats, Inbred Strains | 1983 |
Pharmacology of disodium (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate.
Topics: Animals; Bone and Bones; Bone Development; Bone Resorption; Calcium; Diphosphonates; Homeostasis; Hydroxyproline; Male; Minerals; Pamidronate; Rats | 1980 |
Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretion.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Calcium; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteoporosis; Pamidronate; Parathyroid Glands; Parathyroid Hormone; Phosphates | 1995 |
Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.
Topics: Adolescent; Adult; Alkaline Phosphatase; Diphosphonates; Female; Fibrous Dysplasia of Bone; Follow-Up Studies; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Pain; Pamidronate; Radiography | 1994 |
Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Collagen; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Osteocalcin; Pamidronate | 1994 |
Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Female; Humans; Hydroxyproline; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Treatment Outcome | 1994 |
Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Diphosphonates; Drug Administration Schedule; Humans; Hydroxyproline; Infusions, Intravenous; Middle Aged; Osteitis Deformans; Pamidronate; Time Factors; Treatment Outcome | 1994 |
Intravenous pamidronate in Paget's disease--response is dependent on radiographic and biochemical severity.
Topics: Alkaline Phosphatase; Diphosphonates; Dose-Response Relationship, Drug; Humans; Hydroxyproline; Infusions, Intravenous; Osteitis Deformans; Pain Measurement; Pamidronate; Radiography; Severity of Illness Index | 1994 |
Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
Topics: Amino Acids; Biomarkers; Bone Resorption; Calcitonin; Chromatography, High Pressure Liquid; Diphosphonates; Fluorometry; Humans; Hydroxyproline; Injections, Intravenous; Osteitis Deformans; Pamidronate | 1993 |
Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Topics: Adenoma; Adult; Alkaline Phosphatase; Bone and Bones; Calcitriol; Calcium; Creatinine; Diphosphonates; Female; Humans; Hydroxyproline; Hypercalcemia; Male; Middle Aged; Pamidronate; Parathyroid Hormone; Parathyroid Neoplasms; Phosphates | 1993 |
Determinants of remission of Paget's disease of bone.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bone and Bones; Diphosphonates; Female; Humans; Hydroxyproline; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Regression Analysis; Remission Induction; Time Factors | 1993 |
Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alkaline Phosphatase; Bone Density; Data Interpretation, Statistical; Diphosphonates; Female; Forearm; Humans; Hydroxyproline; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteitis Deformans; Pamidronate; Parathyroid Hormone | 1993 |
Therapeutic strategy in Paget's disease of bone.
Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Analgesics, Non-Narcotic; Biomarkers; Bone and Bones; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Longitudinal Studies; Male; Middle Aged; Osteitis Deformans; Pamidronate; Radiography; Risk Assessment; Skull | 1995 |
Cyclical pamidronate infusions in postmenopausal osteoporosis.
Topics: Adult; Aged; Alkaline Phosphatase; Bone Density; Bone Remodeling; Calcium; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Infusions, Intravenous; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Pamidronate | 1996 |
Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
Topics: Adult; Aged; Amino Acids; Analysis of Variance; Biomarkers; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Diphosphonates; Female; Humans; Hydroxyproline; Middle Aged; Osteolysis; Pamidronate; Postmenopause; Regression Analysis | 1997 |
Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment.
Topics: Animals; Anti-Bacterial Agents; Biomarkers; Bone Development; Calcium; Demeclocycline; Diphosphonates; Dose-Response Relationship, Drug; Femur; Fluoresceins; Growth Plate; Hydroxyproline; Imidazoles; Indicators and Reagents; Injections, Subcutaneous; Male; Pamidronate; Rats; Rats, Sprague-Dawley; Tibia; Zoledronic Acid | 1997 |
A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis.
Topics: Adult; Aged; Bone Resorption; Diphosphonates; Female; Humans; Hydroxyproline; Male; Middle Aged; Models, Biological; Osteoporosis; Pamidronate | 2002 |
Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy.
Topics: Administration, Oral; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Remodeling; Child; Diphosphonates; Drug Administration Schedule; Female; Humans; Hydroxyproline; Injections, Intravenous; Osteitis Deformans; Pamidronate | 2004 |